Showing results (131-140 of 315) with videos related to
Sort By:
Pageof 32
Cancer|June 29, 2006
The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.Current Medical Research and Opinion|March 1, 2014
Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registryE David Crawford, Mark C Scholz, Ashok J Kar, et al.Journal of the National Cancer Institute|October 19, 2013
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapySusan Halabi, Chen-Yen Lin, Eric J Small, et al.BJU International|March 19, 2016
Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancerNeal D Shore, Franklin Chu, Judd Moul, et al.The Journal of Urology|July 28, 2011
Methods of developing UWIN, the modified American Urological Association symptom scoreAl B Barqawi, Kathryn F Sullivan, E David Crawford, et al.Cancer|September 3, 2005
Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group studyUlka N Vaishampayan, James R Faulkner, Eric J Small, et al.Urologic Oncology|February 19, 2017
Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer DatabaseArya Amini, David Raben, E David Crawford, et al.Cancer|April 4, 2003
Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trialStuart Hinton, Paul J Catalano, Lawrence H Einhorn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
Surgical factors influence bladder cancer outcomes: a cooperative group reportHarry W Herr, James R Faulkner, H Barton Grossman, et al.The Journal of Urology|September 18, 2007
Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916R Bruce Montgomery, Bryan Goldman, Catherine M Tangen, et al.Pageof 32